Business Context and Reporting Period
This Form 8-K is a current report filed by PharmAthene, Inc. (not Altimmune, Inc.) on August 12, 2008. The filing announces the company's financial results for the fiscal quarter ended June 30, 2008. The registrant is incorporated in Delaware with principal executive offices in Annapolis, Maryland.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a notification that a press release containing these details has been issued and is attached as Exhibit 99.1. No financial data is embedded directly within the body of this 8-K summary.
Material Changes
The filing does not contain specific data regarding material changes versus the prior comparable period. It references the attached press release for the announcement of results for the quarter ended June 30, 2008.
Guidance, Outlook, and Risks
The text does not include management commentary, forward-looking guidance, specific risks, or contingencies. It notes that the information in this report, including the press release, is not deemed "filed" for purposes of Section 18 of the Exchange Act and shall not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the correct registrant name is PharmAthene, Inc., as the input metadata incorrectly listed Altimmune, Inc.
- Review Exhibit 99.1 (the press release dated August 12, 2008) to obtain actual revenue, net loss, and cash position figures.
- Confirm the fiscal quarter end date of June 30, 2008 for accurate period-over-period analysis.
- Note that this 8-K is a notification of results rather than a detailed financial statement itself.